News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Investor
Can-Fite BioPharma (CFBI) Files June 30, 2014 Interim Financial Statements 9/18/2014
Oncothyreon Inc. (ONTY) Announces Proposed Public Offerings 9/18/2014
Oncothyreon Inc. (ONTY) Prices $40 Million Concurrent Public Offerings Of Common Stock And Preferred Stock 9/18/2014
Nuvilex (NVLX) Updates Shareholders On Recent Activities And Discusses Future Plans For Development Of Treatments For Cancer And Diabetes 9/18/2014
Agilent Technologies Inc. (A) Board Of Directors Approves Separation Of Keysight, Declares Special Dividend Distribution Of Keysight Stock 9/18/2014
Tokai Pharmaceuticals Announces Pricing Of Initial Public Offering 9/17/2014
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 9/17/2014
FEI Company Announces Quarterly Cash Dividend Of $0.25 Per Share 9/17/2014
Synereca Pharmaceuticals Announces Financing Led By Accele Venture Partners 9/17/2014
Novadaq Corp. To Host Analyst & Investor Day On November 17, 2014 9/17/2014
Aratana Therapeutics (PETX) Announces Proposed Public Offering 9/17/2014
Chindex International, Inc. (CHDX) Stockholders Approve Merger 9/17/2014
RXi Pharmaceuticals (RXII) Strengthens Intellectual Property Portfolio 9/17/2014
Auxilium Pharmaceuticals (AUXL) Responds To Unsolicited Proposal From Endo International plc (ENDP) 9/17/2014
Celator Pharmaceuticals, Inc. To Ring The NASDAQ Stock Market Closing Bell On September 17, 2014 9/17/2014
Aastrom Biosciences, Inc. (ASTM) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/17/2014
MGB Biopharma Limited Secures $6.4 MillionTo Advance Its Novel Lead Antibacterial, MGB-BP-3, Into Clinical Development 9/17/2014
Syneron Inc. Announces Details For Upcoming Investor Meeting 9/16/2014
Valeant Pharmaceuticals International (VRX) Announces Redemption Of All Of The Outstanding $500.0 Million Aggregate Principal Amount Of Its 6.75% Senior Notes Due 2017 9/16/2014
Nordic Nanovector: Final Result Of The Subsequent Offering 9/16/2014
Pivotal Therapeutics Inc. Grants Incentive Stock Options 9/16/2014
CorMedix (CRMD) Amends And Restates Outstanding Securities To Remove Provisions Causing Derivative Liability Classification 9/16/2014
Opexa Therapeutics (OPXA) Announces Termination of Public Offering of Common Stock 9/16/2014
Allergan Inc. (AGN) To Hold Special Meeting Of Stockholders On Originally Scheduled Date Of December 18 Without Restriction 9/16/2014
Opexa Therapeutics (OPXA) Announces Proposed Public Offering Of Common Stock 9/16/2014
Celator Pharmaceuticals, Inc. To Ring The NASDAQ Stock Market Closing Bell 9/16/2014
Ampio Pharmaceuticals, Inc. (AMPE) Announces Webcast For Annual Shareholder Meeting 9/15/2014
Inovio Pharmaceuticals (INO) Begins Trading On NASDAQ Global Select Market Exchange 9/15/2014
PDL BioPharma, Inc. (PDLI) Completes Regular Quarterly Dividend Payment 9/15/2014
Antibe Therapeutics Inc. Commences Trading On The U.S. OTCQX Marketplace 9/15/2014
Akebia Therapeutics, Inc. (AKBA) To Ring The NASDAQ Stock Market Opening Bell 9/12/2014
Abbott Announces New $3 Billion Share Repurchase Program, Declares Dividend 9/12/2014
Novavax, Inc. (NVAX) To Host 2nd Annual Analyst And Investor Meeting 9/12/2014
NPS Pharmaceuticals, Inc. (NPSP) Stock Trading Halted Today; FDA Advisory Committee To Review Natpara® Biologics License Application 9/12/2014
Veeva Systems, Inc. To Host Analyst Day On Sept. 17, 2014 9/12/2014
Kolltan Pharmaceuticals Inc. Files Registration Statement for Proposed Initial Public Offering 9/12/2014
Aastrom Biosciences, Inc. (ASTM) Announces Pricing Of Public Offering Of Common Stock 9/11/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
Orexigen Therapeutics, Inc. (OREX) To Host Conference Call And Webcast At 8:30 AM Eastern Time September 11, 2014 9/11/2014
Portage Announces Proposed Private Placement 9/11/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
Roche (RHHBY) Again Ranked Most Sustainable Healthcare Company In The Dow Jones Sustainability Indices 9/11/2014
Fibrocell Science, Inc. Hosting R&D Day On September 24, 2014 9/11/2014
Intuitive Surgical, Inc. (ISRG) Reports New Employee Option Grants For September 2014 9/10/2014
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 9/10/2014
BrainStorm Cell Therapeutics Inc. Provides Update On NASDAQ Uplisting Process 9/10/2014
TNI BioTech Announces Results Of Annual Shareholders Meeting 9/9/2014
Polydex Pharmaceuticals (POLXF) Reports Equipment Upgrades And Continued Profitability 9/9/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 9/9/2014
Relmada Therapeutics Provides Its First Corporate Update As A Public Company 9/9/2014
Regeneus (ASX:RGS) Share Purchase Plan Closes Oversubscribed 9/9/2014
MabVax Therapeutics, Inc. Receives Stockholder Approval For Name Change And Reverse Stock Split Resulting From Merger With Telik, Inc. (TELK) 9/9/2014
Clovis Oncology (CLVS) Announces Exercise In Full By Initial Purchasers Of Their Option To Purchase An Additional $37.5 Million Aggregate Principal Amount Of The Company’s 2.50% Convertible Senior Notes Due 2021 9/9/2014
ContraFect Corporation (CFRXU) Announces Separation Of Units Sold In IPO 9/9/2014
PDL BioPharma, Inc. (PDLI) Announces Conversion Rate Adjustments For Convertible Notes 9/8/2014
EndoStim Files Registration Statement For Proposed Initial Public Offering Of Common Stock 9/8/2014
Intrexon Corporation Announces Filing Of Form S-3 Shelf Registration Statement 9/8/2014
Matinas BioPharma Approved To Trade On OTCQB Venture Stage Marketplace 9/8/2014
NeoStem, Inc. Letter To Shareholders 9/8/2014
Asterias Biotherapeutics Announces Record Date For Distribution Of BioTime (BTX) Warrants To Holders Of Asterias Series A Common Stock 9/8/2014
BioBlast Pharma (ORPN) To Ring The NASDAQ Stock Market Opening Bell 9/8/2014
La Jolla Pharmaceutical Company (LJPC) To Provide Corporate Overview At The Rodman & Renshaw 16th Annual Global Investment Conference 9/8/2014
Axxess Pharma, Inc. Provides Shareholder Update 9/8/2014
Panther Biotechnology Announces A 6-1 Forward Stock Split To Increase Liquidity Of Their Common Stock And Intent To List On The NYSE Or NASDAQ 9/8/2014
Loxo Oncology (LOXO) Announces Closing Of Initial Public Offering And Partial Exercise Of Over-Allotment Option 9/5/2014
Ablynx (ABLYF) Establishes Sponsored Level I ADR Programme In The United States 9/5/2014
Allergan Inc. (AGN) Provides Update On Written Requests From Pershing Square Regarding Special Meeting Of Stockholders 9/5/2014
InterMune, Inc. (ITMN) Announces Anticipated Fundamental Change For 5.00% Convertible Senior Notes Due 2015 9/5/2014
Depomed, Inc. (DEPO) Announces Pricing Of Upsized $300 Million Convertible Senior Notes Due 2021 9/5/2014
Inovio Pharmaceuticals (INO) To List On NASDAQ 9/4/2014
Clovis Oncology (CLVS) Announces Pricing Of $250 Million Of Convertible Senior Notes 9/4/2014
Perrigo Company (PRGO) Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 9/4/2014
Alere Inc. (ALR) Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock 9/4/2014
ReVance Therapeutics, Inc. (RVNC) Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/3/2014
Otonomy, Inc. (OTIC) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/3/2014
BioDelivery Sciences International (BDSI) To Ring The NASDAQ Stock Market Opening Bell 9/3/2014
Horizon Discovery Group Plc: Notice Of Interim Results 9/3/2014
Clovis Oncology (CLVS) To Offer $200 Million Of Convertible Senior Notes 9/3/2014
Depomed, Inc. (DEPO) Announces Offering Of $230 Million Convertible Senior Notes Due 2021 9/3/2014
BioDelivery Sciences International (BDSI) To Ring The NASDAQ Stock Market Opening Bell 9/3/2014
Marinus Pharmaceuticals (MRNS) Announces Exercise Of Over-Allotment Option In Public Offering Of Common Stock 9/2/2014
Agile Therapeutics, Inc. To Ring The NASDAQ Stock Market Closing Bell 9/2/2014
Aurinia (ISA.TO) To Begin Trading On The NASDAQ Global Market 9/2/2014
Cellectis (ALCLS): Genome Engineering & CART Cells: At The Forefront Of Immuno-Oncology 9/2/2014
Nordic Nanovector – Subsequent Offering 9/2/2014
VentiRx Pharmaceuticals, Inc. Provides Corporate And Clinical Update 9/2/2014
Stellar Biotechnologies, Inc. Reports On Unusual Trading Activity 9/2/2014
Daxor Corporation (DXR) Announces Filing Of Form N-CSR For June 30, 2014 9/2/2014
Orexo AB (ORXOF) Has Successfully Completed Its Private Placement Of Approx. SEK 346.5 Million 8/29/2014
Advanced Cell Technology Announces 1:100 Reverse Stock Split 8/28/2014
Allenex AB: Sales +15% Jan-Jun 2014 8/28/2014
ThromboGenics NV (TBGNF) Business Update H1 2014 8/28/2014
Facing Shareholder Demands, Allergan Inc. (AGN) Reluctantly Sets A Date For Special Meeting 8/27/2014
NeuroSigma, Inc. Files Registration Statement for Proposed Initial Public Offering 8/27/2014
Sinovac Biotech Ltd. (SVA) Announces Results Of 2014 Annual General Meeting Of Shareholders 8/27/2014
Transcat, Inc. (TRNS) Increases Secured Revolving Credit Facility 8/27/2014
BioDelivery Sciences International (BDSI) To Host Investor And Analyst Event And Webcast Friday, September 5 On BUNAVAIL™ Launch And Pipeline 8/27/2014
Allergan Inc. (AGN) To Request California Federal Court Block Valeant Pharmaceuticals International (VRX) And Pershing Square From Voting Shares Acquired In Violation Of Insider Trading Laws 8/27/2014
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential 8/26/2014
Mesoblast Limited (MSB.AX) Unveils Path To Bring Its Key Products To Market 8/26/2014
Viropro Inc. (VPRO) Initiates Interim Debt Financing Of Up To $500,000 8/26/2014
Wound Management Technologies, Inc. Announces Its 2014 Annual Meeting Of Shareholders 8/26/2014
Marinus Pharmaceuticals (MRNS) To Ring The Opening Bell Of The NASDAQ Stock Market 8/25/2014
Vaccinogen Completes Initial Closing Of An $80 Million Financing 8/25/2014
China Cord Blood Corporation Receives Notice Of Transaction Regarding Its 7% Senior Convertible Note Due 2017 Held By Golden Meditech 8/25/2014
Landauer (LDR) Declares Regular Cash Dividend 8/25/2014
Abbott Laboratories (ABT) Commences Tender Offer For All Outstanding Ordinary Shares And American Depositary Shares Of CFR Pharmaceuticals 8/25/2014
Asterias Biotherapeutics Announces Investor Briefing Conference Call And Webcast 8/25/2014
BioGenerator Funds Woman-led EDIS Solutions 8/25/2014
Letter To The Ampio Pharmaceuticals, Inc. (AMPE) Shareholders In Regard To The STEP Study And Ampio's Plans For The Ampion™ BLA 8/25/2014
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 8/25/2014
Pershing Square Submits Requisite Requests From Allergan Inc. (AGN) Shareholders To Call Special Meeting 8/25/2014
Easton Pharmaceuticals (OP: EAPH) Announces Financing Update; Provides Additional Due Diligence Documents To Canadian Based Brokerage Firm Towards Financing 8/25/2014
China Biologic Products Pays $87 Million For Additional 20 Percent Stake In Subsidiary 8/25/2014
Lemelson Capital Comments On Large Institutional Selling In Shares Of Ligand Pharmaceuticals Inc. (LGND) Amidst Company's Insolvency And Mounting Going Concern Risk 8/25/2014
NeoGenomics, Inc. (NGNM.OB) Announces Closing Of Recent Equity Offering And Exercise In Full Of Underwriters' Over-Allotment Option 8/22/2014
Allergan Inc. (AGN) Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International (VRX) Bid 8/22/2014
Cellectar Biosciences  (NVLT) Announces Closing Of Public Offering And Partial Exercise Of Underwriter's Over-Allotment Option 8/21/2014
Asterias Biotherapeutics Appoints Two Independent Directors And Announces Completion Of Series A Common Stock Distribution 8/21/2014
Henry Schein, Inc. (HSIC) To Present At Two Investor Conferences In September 8/21/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 8/21/2014
Compugen Ltd. (CGEN) Reacquires Baize’s Financial Interest In Pipeline Product Candidates 8/21/2014
Marina Biotech, Inc. (MRNA) Regains Compliance With Exchange Act Reporting Obligations 8/21/2014
Bao Hao Investment Management Co. Affiliate Takes Equity Stake In 20/20 GeneSystems, Inc. 8/21/2014
PTC Therapeutics, Inc. (PTCT) To Participate At Upcoming Investor Conferences 8/21/2014
Regeneron Pharmaceuticals, Inc. (REGN) To Ring The NASDAQ Stock Market Opening Bell 8/20/2014
Lorus Therapeutics Inc. (LRP) Announces Results Of Annual And Special Meeting Of Shareholders 8/20/2014
Enzymotec Announces An Annual General Meeting Of Shareholders 8/20/2014
Ocular Therapeutix, Inc. (OCUL) Announces Exercise Of Over-Allotment Option 8/20/2014
Adamis Pharmaceuticals (ADMP) Announces Private Placement 8/20/2014
Celladon Corporation Announces Closing Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares 8/19/2014
Immune Pharmaceuticals, Inc. Announces Approval For Listing On The NASDAQ Capital Market 8/19/2014
Regeneron Pharmaceuticals, Inc. (REGN) Announces Upcoming 2014 Investor Conference Presentations 8/19/2014
Mallinckrodt Now A Component Of The S&P 500 Index 8/19/2014
Invitation To Extraordinary General Meeting Of Shareholders Of Recipharm AB 8/19/2014
Regeneron Pharmaceuticals, Inc. (REGN) To Ring The NASDAQ Stock Market Opening Bell 8/19/2014
Northwest Biotherapeutics (NWBO) Completes The Closing Of Its $17.5 Million Convertible Note Offering 8/19/2014
Silicon Valley’s Hottest Tech Accelerator, Y Combinator, To Debut Biotech Startups 8/19/2014
H&Q Life Sciences Investors Declares Stock Distribution 8/18/2014
Resverlogix Corporation (RVX.TO) Closes Additional $30 Million From Citibank Loan 8/18/2014
TNI BioTech Provides 2nd Notice of Annual Meeting September 4, 2014 8/18/2014
Dyadic International, Inc. Files Form 10 Registration Statement 8/18/2014
Insmed Incorporated (INSM) Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares 8/18/2014
Cellectar Biosciences  (NVLT) Announces Pricing Of $12,500,000 Public Offering And Listing On The Nasdaq Capital Market 8/15/2014
NeoGenomics, Inc. (NGNM.OB) Announces Public Offering Of Common Stock 8/15/2014
TNI BioTech Announces An Extension To The Record Date Of Its Wholly Owned Subsidiary, Cytocom Inc., And Dividend Now Set For September 30, 2014 8/15/2014
Resverlogix Corporation (RVX.TO) Shareholders Approve Additional $30 Million From Citibank Loan 8/14/2014
Immune Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results And Provides Update On Bertilimumab Commencement Of Phase 2 Clinical Trials 8/14/2014
VistaGen Therapeutics, Inc. Announces Reverse Stock Split 8/14/2014
Northwest Biotherapeutics (NWBO) Announces Pricing Of $17.5 Million Offering Of Convertible Notes 8/14/2014
Pressure BioSciences, Inc. (BBII) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/14/2014
Novozymes, Inc. (NZYMb.CO) Increases 2014 Profit Outlook 8/14/2014
Struggling Dendreon Corporation (DNDN) Plunges After Warning Investors Of Debt Woes 8/14/2014
Celladon Corporation Announces Pricing Of Public Offering Of Common Stock 8/13/2014
Intellect Neurosciences, Inc. Issues Letter To Shareholders 8/13/2014
NanoViricides, Inc. (NNVC.PK) To Ring Opening Bell At New York Stock Exchange 8/13/2014
Insmed Incorporated (INSM) Announces Pricing Of Public Offering Of Common Stock 8/13/2014
Ligand Pharmaceuticals Inc. (LGND) Prices Offering Of $225 Million Of Convertible Senior Notes 8/13/2014
Novogen Limited (NVGN) Announces Results Of General Meeting Of Shareholders 8/13/2014
Pressure BioSciences, Inc. (BBII) To Discuss Second Quarter 2014 Financial Results And Provide A Business Update 8/13/2014
Israel's VBL Therapeutics (VBLX) Terminates NASDAQ IPO Due To Shareholder Mishap 8/12/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Prices $300 Million Convertible Senior Notes Offering 8/12/2014
Apricus Biosciences (APRI) Enters Into Common Stock Purchase Agreement With Aspire Capital 8/12/2014
Ligand Pharmaceuticals Inc. (LGND) Announces Proposed Offering Of $225 Million Of Convertible Senior Notes And Announces $200 Million Share Repurchase Program 8/12/2014
Insmed Incorporated (INSM) Announces Proposed Public Offering Of Common Stock 8/12/2014
Organovo Highlights Liver Toxicology Achievement, Reports Q1 Fiscal 2015 Results 8/12/2014
Cannabis Science Inc. Increases Equity Position To 50.1% In Michigan Green Technologies LLC, Positioning Company As Leader In Evolving Michigan Medical Cannabis And Hemp Industries 8/12/2014
Big Investors Ask Drugmakers And Biotechs To Support Biosimilars 8/12/2014
Orthocell Successfully Lists On Australian Securities Exchange 8/12/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Announces Intention To Offer $250 Million Of Convertible Notes 8/11/2014
Cellular Biomedicine Group (CBMG) To Ring The NASDAQ Stock Market Closing Bell 8/11/2014
TONIX Pharmaceuticals, Inc. Announces Transfer To The NASDAQ Global Market 8/11/2014
PDL BioPharma, Inc. (PDLI) Announces Delay In Filing Quarterly Report On Form 10-Q 8/11/2014
Mast Therapeutics (MSTX) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/11/2014
Bio-Techne Declares Dividend 8/11/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 8/8/2014
Galapagos NV (GLPG.BR) Cash Position Of €232 M Provides Solid Basis For R&D Pipeline Investment 8/8/2014
Advisor ISS Backs Ackman's Call For Allergan Inc. (AGN) Meeting, Event Could Support The Removal Of Directors, Sale To Valeant Pharmaceuticals International (VRX) 8/7/2014
Press Release Issued Under The Early Warning System/Sale Of Shares Of Nymox Pharmaceutical (NYMX) 8/7/2014
Celladon Corporation Announces Commencement Of Public Offering Of Common Stock 8/7/2014
Institutional Shareholder Services (ISS) Recommends Allergan Inc. (AGN) Shareholders Call A Special Meeting Of Shareholders 8/7/2014
QLT Inc. (QLTI) Announces Adoption Of Advance Notice Policy 8/7/2014
CVS Caremark Corporation (CVS) Announces Cash Tender Offers For Its 6.250% Senior Notes Due 2027, 6.125% Senior Notes Due 2039, 5.750% Senior Notes Due 2041 And 5.750% Senior Notes Due 2017 8/7/2014
Aoxing Pharmaceutical Company Inc. (AXN) Receives Notice Of Extension From NYSE MKT LLC 8/7/2014
AmerisourceBergen Corporation (ABC) Declares Quarterly Dividend 8/7/2014
Jazz Pharmaceuticals plc (JAZZ) Announces Proposed Offering Of $500 Million Of Exchangeable Senior Notes 8/7/2014
Zoetis (ZTS) Will Hold Its Inaugural Investor Day On November 18 8/5/2014
PTC Therapeutics, Inc. (PTCT) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 8/4/2014
Telik, Inc. (TELK) Announces Plans For Special Meeting Of Stockholders And Transition To MabVax Therapeutics, Inc. 8/4/2014
Applied Genetic Technologies Corporation Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/4/2014
Metabolix, Inc. Enters Into Private Placement Agreement With Investors To Raise $25 Million In Equity Financing 8/4/2014
Arena Pharmaceuticals, Inc. (ARNA) Provides Corporate Update And Reports Second Quarter 2014 Financial Results 8/1/2014
InVivo Therapeutics Corporation (NVIV) Announces Posting Of Management Presentation Recording From Annual Shareholders Meeting 8/1/2014
Pfizer Inc. (PFE)’s Stake In Cellectis (ALCLS)’ Capital Is Welcomed By Its Shareholders 8/1/2014
Israeli Biotech Macrocure Sets Terms for $75 Million IPO 7/31/2014
Epilepsy Biotech Marinus Pharmaceuticals (MRNS) Prices IPO At $10/Share 7/31/2014
China Cord Blood Corporation Files Its Annual Report On Form 20-F 7/31/2014
Zealand Pharma  (ZEAL.CO) Reports Increased Lyxumia® Royalty Revenue For H1 2014 And Informs Of Status Update As Provided By Sanofi 7/31/2014
Senomyx, Inc. (SNMX) Announces Corporate Update And Second Quarter 2014 Financial Results 7/31/2014
Intellect Neurosciences, Inc. Issues Letter To Shareholders 7/31/2014



//-->